Microbiotica’s microbiome therapy showed 63% remission in ulcerative colitis phase 1b trial

Microbiotica’s microbiome therapy showed 63% remission in ulcerative colitis phase 1b trial
11 February  2026
European Biotechnology Magazine

View Item